+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The kinetics and temporal expression of T-cell activation-associated antigens CD15 , CD30 , EMA, and CD11c by benign activated T cells



The kinetics and temporal expression of T-cell activation-associated antigens CD15 , CD30 , EMA, and CD11c by benign activated T cells



Hematologic Pathology 6(4): 193-202



Cell surface antigens, including CD71 (T9), CD38 (T10), HLA-DR, CD25 (IL2-R), CD15 (LeuM1), CD30 (Ki-1), epithelian membrane antigen (EMA), and CD11c (LeuM5), have been identified on the surface of neopastic T-cells. The significance of this expression is unknown since the expression of these antigens by benign T cells has not been fully investigated. In this study the kinetics, temporal relation and hierarchy of expression of these eight cell surface antigens by purified normal peripheral blood T cell following activation with phytophemagglutinin (PHA) were investigated using one- and two-color flow cytometry. All eight antigens were expressed in a hierarchical manner following activation of normal peripheral blood T cells with PHA. The sequence of antigen expression and the initial time point of this expression was: CD38, lt 24 h; CD71, CD25, 24 h; EMA, HLA-DR, CD15, 48-72 h; CD30, 72 h; and CD11c, 96-120 h. The maximum percentage of T cells expressing each antigen and the time of maximum expression was: CD38 96% and 14 and 17 days; CD71 88%, CD25 94%, EMA 55%, and CD30 31% at 96 h; CD15 56% at 120 h; HLA-DR 30% at 168 h; and CD11c 42% h. The expresson of these 8 antigens clustered into six distinct immunophenotypic constellations: Group I: None; Group II: CD38 with CD71 and/or CD25; Group III: CD38, CD71, CD25 with HLA-DR, CD15 and/or EMA; Group IV: CD38, CD71, CD25, EMA, HLA-DR with CD15, CD30 and/or CD11c; Group V: CD38, CD25, CD11c with CD71. EMA and/or HLA-Dr; Group VI: CD38 with CD25 and/orCD11c. Finally, EMA and CD11c were preferentially expressed by CD4 and CD8 T cells, respectively. In summary, these results demonstrate that all eight antigens (1) are associated with T-cell activation, (2) are expressed in a hierarchical manner following activation, and (3) that this experssion clusters into distinct immunophenotypic constellation, and (3) this this expression clusters into distinct immunophenotypic constellations.

(PDF emailed within 1 workday: $29.90)

Accession: 033856105

Download citation: RISBibTeXText


Related references

A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?. Leukemia and Lymphoma 51(6): 1148-1151, 2010

Kinetics and temporal expression of activation antigens on normal and neoplastic t cells. Laboratory Investigation 60(1): 16A, 1989

Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells. American Journal of Pathology 136(1): 29-37, 1990

The pattern of CD15, CD30 and Bcl-2 expression in diffuse large B-cell lymphoma. Medical Journal of Malaysia 61(4): 416-421, 2007

Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. Journal of Clinical Oncology 29(32): E789-E791, 2011

Activation of human phagocytes through carbohydrate antigens (CD15, sialyl-CD15, CDw17, and CDw65). Journal of Immunology 148(10): 3221-3229, 1992

Kinetics of expression of T-cell "activation" antigens on in vivo- and in vitro-stimulated T cells. Diagnostic Immunology 1(3): 104-111, 1983

Expression of b cell and activation panel antigens on in vitro stimulated b cells and their role in homotypic adhesion of normal activated b cells. Tissue Antigens 33(2): 327, 1989

Monoclonal antibodies detecting human t cell activation antigens development of monoclonal antibodies and expression of antigens on activated t cells an leukemic cell lines. Federation Proceedings 44(3): 787, 1985

Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. European Journal of Immunology 27(9): 2239-2244, 1997

Acquisition of CD30 and CD15 accompanied with simultaneous loss of all pan-T-cell antigens in a case of histological transformation of mycosis fungoides with involvement of regional lymph node: an immunophenotypic alteration resembling classical Hodgkin lymphoma. American Journal of Dermatopathology 37(3): 249-253, 2015

AML1/ETO inhibits AML1/CCAAT-enhancer binding protein-alpha mediated activation of the CD11c promoter and represses CD11c expression in HL60 cells. Haematologica 88(8): 956-958, 2003

CD30 expression on allergen and nonallergen specific T cell lines Expression of IL-4 mRNA by T CD4 or CD8 CD30+/-cells. Journal of Allergy & Clinical Immunology 103(1 PART 2): S108, 1999

Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle. European Journal of Immunology 16(3): 248-251, 1986

An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30. Cancer Research 58(6): 1116-1119, 1998